Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro

Pasireotide is a somatostatin analog (SSA) that targets somatostatin receptor subtype 1 (SST1), SST2, SST3, and SST5 with a high affinity. Pasireotide has a better antisecretory effect in acromegaly, Cushing's disease, and neuroendocrine tumors than octreotide. In this study, we compared the ef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Graillon, Thomas, Romano, David, Defilles, Céline, Lisbonis, Christophe, Saveanu, Alexandru, Figarella-Branger, Dominique, Roche, Pierre-Hugues, Fuentes, Stéphane, Chinot, Olivier, Dufour, Henry, Barlier, Anne
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589664/
https://ncbi.nlm.nih.gov/pubmed/28903425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19517
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars